等待开盘 08-17 09:30:00 美东时间
-0.080
-3.92%
绩优股普升!量子计算公司昆腾飙升64%,近三年来首度非GAAP单季盈利;NIQ劲升42%,Q2 EPS扭亏大幅增长;Fermi升逾21%,签署大规模AI数据中心长期租约>>
08-12 15:54
Alector reported Q2 2026 financial results, with $172.8 million in cash, supporting operations through 2027. The company advanced its Alector Brain Carrier (ABC) platform across antibodies, enzymes, and siRNA for neurodegenerative diseases. Key programs include AL137, an anti-amyloid beta antibody for Alzheimer’s disease, AL064/AL164 (tau siRNA for AD), and AL050 (enzyme therapy for Parkinson’s disease). CEO Arnon Rosenthal highlighted steady pro...
08-06 20:05
(来源:中国医药报) 转自:中国医药报 近年来,与中枢神经系统(CNS)疾病相关的全球疾病负担持续上升,造成巨大的经济影响。预计到2030年,仅心理健康问题造...
08-06 07:59
Alector ( ($ALEC) ) has provided an announcement. On October 21, 2025, Alector ...
07-09 04:32
https://www.sec.gov/ix?doc=/Archives/edgar/data/1653087/000119312526298526/alec-20260706.htm
07-09 04:20
Rani Therapeutics appoints Nicholas Maestas as Chief Financial Officer, effective immediately. Maestas brings over 10 years of financial leadership experience in biotechnology, including roles at Tempest Therapeutics and Alector. He succeeds Svai Sanford, who is departing for another opportunity. Maestas expressed enthusiasm for advancing Rani's oral delivery platform technology, RaniPill®, to address the challenge of effective oral delivery of b...
06-29 12:00
Alector shares are trading lower after the company reported worse-than-expected...
05-08 23:24
$125,000,000Common StockWe have entered into a sales agreement with TD Securities (USA) LLC ("TD Cowen") relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In
05-08 06:09
Alector (NASDAQ:ALEC) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.35) by 40 percent. This is a 48.78 percent increase over losses of $(0.41) per share from the same
05-08 04:34